Celesio shareholder opposes McKesson's $8.3B offer
AP - Tue Dec 10, 5:57PM CST
SAN FRANCISCO (AP) — McKesson Corp.'s $8.3 billion bid to buy rival pharmaceutical drug distributor Celesio AG is facing opposition from a major Celesio shareholder that contends the proposed sales price is too low.